Riluzole increases glutamate uptake by cultured C6 astroglial cells

International Journal of Developmental Neuroscience

Volumn 31, Issue 7, 2013, Pages 482-486

  Dall'Igna, Oscar P ^a   Bobermin, Larissa D ^a   Souza, Diogo O ^a   Quincozes Santos, André ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Excitotoxicity; Fibroblast growth factor receptor 1; MAPK ERK; Phosphatidylinositol 3 kinase; Protein kinase C; Riluzole

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; BISINDOLYLMALEIMIDE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLUTAMIC ACID; GLUTATHIONE; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C INHIBITOR; REACTIVE OXYGEN METABOLITE; RILUZOLE; WORTMANNIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; CELL CULTURE; COLORIMETRY; CONTROLLED STUDY; DRUG APPROVAL; DRUG MECHANISM; HUMAN; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION;

ALS; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ANOVA; BDNF; BIS II; BISINDOLYLMALEIMIDE II; BRAIN-DERIVED NEUROTROPHIC FACTOR; EAAT; EDTA; ERK; ETHYLENE-DIAMINETETRACETIC ACID; EXCITATORY AMINO ACID TRANSPORTER; EXCITOTOXICITY; EXTRACELLULAR-SIGNAL REGULATED KINASE; FGFR SUBSTRATE 2Α; FGFR1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FRS2Α; MAPK; MAPK/ERK; MITOGEN-ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PI3K; PKC; PROTEIN KINASE C; RILUZOLE;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACID TRANSPORTER 3; GLIOMA; GLUTAMIC ACID; GLUTATHIONE; L-LACTATE DEHYDROGENASE; RATS; REACTIVE OXYGEN SPECIES; RILUZOLE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; TIME FACTORS;

EID: 84880269202     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2013.06.002     Document Type: Article

References (34)

1. Aoyama K., Watabe M., Nakaki T. Regulation of neuronal glutathione synthesis. Journal of Pharmacological Sciences 2008, 108:227-238.
2. Azbill R.D., Mu X., Springer J.E. Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Research 2000, 871:175-180.
3. Beart P.M., O'shea R.D. Transporters for l-glutamate: an update on their molecular pharmacology and pathological involvement. British Journal of Pharmacology 2007, 150:5-17.
4. Bellingham M.C. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?. CNS Neuroscience & Therapeutics 2011, 17:4-31.
5. Bensimon G., Ludolph A., Agid Y., Vidailhet M., Payan C., Leigh P.N. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009, 132:156-171.
6. Bonnefont-Rousselot D., Lacomblez L., Jaudon M., Lepage S., Salachas F., Bensimon G., Bizard C., Doppler V., Delattre J., Meininger V. Blood oxidative stress in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 2000, 178:57-62.
7. Browne R.W., Armstrong D. Reduced glutathione and glutathione disulfide. Methods in Molecular Biology 1998, 108:347-352.
8. Davis K.E., Straff D.J., Weinstein E.A., Bannerman P.G., Correale D.M., Rothstein J.D., Robinson M.B. Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma. Journal of Neuroscience 1998, 18:2475-2485.
9. Deng Y., Xu Z.F., Liu W., Xu B., Yang H.B., Wei Y.G. Riluzole-triggered GSH synthesis via activation of glutamate transporters to antagonize methylmercury-induced oxidative stress in rat cerebral cortex. Oxidative Medicine and Cellular Longevity 2012, 534705.
10. Doble A. The pharmacology and mechanism of action of riluzole. Neurology 1996, 47:S233-S241.
11. dos Santos A.Q., Nardin P., Funchal C., de Almeida L.M., Jacques-Silva M.C., Wofchuk S.T., Goncalves C.A., Gottfried C. Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Archives of Biochemistry and Biophysics 2006, 453:161-167.
12. Foran E., Trotti D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxidants & Redox Signaling 2009, 11:1587-1602.
13. Fournier K.M., Gonzalez M.I., Robinson M.B. Rapid trafficking of the neuronal glutamate transporter, EAAC1: evidence for distinct trafficking pathways differentially regulated by protein kinase C and platelet-derived growth factor. Journal of Biological Chemistry 2004, 279:34505-34513.
14. Frizzo M.E., Dall'Onder L.P., Dalcin K.B., Souza D.O. Riluzole enhances glutamate uptake in rat astrocyte cultures. Cellular and Molecular Neurobiology 2004, 24:123-128.
15. Gottfried C., Tramontina F., Goncalves D., Goncalves C.A., Moriguchi E., Dias R.D., Wofchuk S.T., Souza D.O. Glutamate uptake in cultured astrocytes depends on age: a study about the effect of guanosine and the sensitivity to oxidative stress induced by H(2)O(2). Mechanisms of Ageing and Development 2002, 123:1333-1340.
16. Katoh-Semba R., Kaneko R., Kitajima S., Tsuzuki M., Ichisaka S., Hata Y., Yamada H., Miyazaki N., Takahashi Y., Kato K. Activation of p38 mitogen-activated protein kinase is required for in vivo brain-derived neurotrophic factor production in the rat hippocampus. Neuroscience 2009, 163:352-361.
17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
18. Matos M., Augusto E., Oliveira C.R., Agostinho P. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience 2008, 156:898-910.
19. Mehta A., Prabhakar M., Kumar P., Deshmukh R., Sharma P.L. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. European Journal of Pharmacology 2013, 698:6-18.
20. Molteni R., Ying Z., Gomez-Pinilla F. Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray. European Journal of Neuroscience 2002, 16:1107-1116.
21. Noh K.M., Hwang J.Y., Shin H.C., Koh J.Y. A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiology of Disease 2000, 7:375-383.
22. Pittenger C., Coric V., Banasr M., Bloch M., Krystal J.H., Sanacora G. Riluzole in the treatment of mood and anxiety disorders. CNS Drugs 2008, 22:761-786.
23. Quincozes-Santos A., Bobermin L.D., Kleinkauf-Rocha J., Souza D.O., Riesgo R., Goncalves C.A., Gottfried C. Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:11-15.
24. Quincozes-Santos A., Bobermin L.D., Tonial R.P., Bambini-Junior V., Riesgo R., Gottfried C. Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions. European Archives of Psychiatry and Clinical Neuroscience 2010, 260:475-481.
25. Rinwa P., Jaggi A.S., Singh N. Pharmacological investigation of memory restorative effect of riluzole in mice. Indian Journal of Pharmacology 2012, 44:366-371.
26. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
27. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes H.M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
28. Rothstein J.D., Van K.M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Annals of Neurology 1995, 38:73-84.
29. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochemistry International 2007, 51:333-355.
30. Swanson R.A., Liu J., Miller J.W., Rothstein J.D., Farrell K., Stein B.A., Longuemare M.C. Neuronal regulation of glutamate transporter subtype expression in astrocytes. Journal of Neuroscience 1997, 17:932-940.
31. Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?. Trends in Pharmacological Sciences 1998, 19:328-334.
32. Tsuchioka M., Hisaoka K., Yano R., Shibasaki C., Kajiatani N., Takebayashi M. Riluzole-induced glial cell line-derived neurotrophic factor production is regulated through fibroblast growth factor receptor signaling in rat C6 glioma cells. Brain Research 2011, 1384:1-8.
33. Van den Bosch L., Van D.P., Bogaert E., Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochimica et Biophysica Acta 2006, 1762:1068-1082.
34. Yip D., Le M.N., Chan J.L., Lee J.H., Mehnert J.A., Yudd A., Kempf J., Shih W.J., Chen S., Goydos J.S. A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clinical Cancer Research 2009, 15:3896-3902.